These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3825221)

  • 21. Studies of natural killer cells in pregnancy. II. The immunoregulatory effect of pregnancy substances.
    Toder V; Nebel L; Elrad H; Blank M; Durdana A; Gleicher N
    J Clin Lab Immunol; 1984 Jul; 14(3):129-33. PubMed ID: 6481789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human peripheral blood monocytes are susceptible to interferon-activated natural killer cells.
    Einhorn S; Anderbring E
    J Clin Lab Immunol; 1985 Apr; 16(4):197-9. PubMed ID: 4020850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis: dysregulation of innate immunity.
    Bos JD; de Rie MA; Teunissen MB; Piskin G
    Br J Dermatol; 2005 Jun; 152(6):1098-107. PubMed ID: 15948970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor-bearing lymphocytes.
    Neville ME
    J Immunol; 1980 Dec; 125(6):2604-9. PubMed ID: 6776195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dendritic cells, natural killer cells and adhesion molecules in psoriasis].
    Zhang M; Zhang YZ; Wang S; Wang L; Li FY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):626-9. PubMed ID: 15460403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
    Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
    J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of natural killer cell activity by a soluble substance released by rat peritoneal cells.
    Zighelboim J; Lichtenstein A; Bick A; Mickel R
    Cancer Res; 1983 May; 43(5):1984-9. PubMed ID: 6339046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
    Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
    Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
    Lister J; Rybka WB; Donnenberg AD; deMagalhaes-Silverman M; Pincus SM; Bloom EJ; Elder EM; Ball ED; Whiteside TL
    Clin Cancer Res; 1995 Jun; 1(6):607-14. PubMed ID: 9816022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
    Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
    J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
    Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
    Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell tolerance licensing and other mechanisms.
    Jonsson AH; Yokoyama WM
    Adv Immunol; 2009; 101():27-79. PubMed ID: 19231592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immune tolerance inducing effects of soluble human leucocyte antigen G1 on natural killer cells and T cells].
    Fang CY; Wu XW; Liang ZH; Chen H; Han JY; Huang YF; Gong FL
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):584-7. PubMed ID: 12887750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer (NK) activity of normal human peripheral blood lymphocytes against erythroleukemic cell line K 562.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):115-26. PubMed ID: 6946049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.